Stéphanie A. Blankenstein

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman et al. · Nature Communications · 2020 · 115 citations · Full text

Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR

Stéphanie A. Blankenstein, Maartje W. Rohaan, W. Martin C. Klop et al. · Annals of Surgery · 2021 · 46 citations · Full text

Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma

Judith M. Versluis, Stéphanie A. Blankenstein, Petros Dimitriadis et al. · Journal for ImmunoTherapy of Cancer · 2024 · 16 citations · Full text

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy

Stéphanie A. Blankenstein, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel et al. · Cancers · 2020 · 14 citations · Full text

18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients

Bernies van der Hiel, Stéphanie A. Blankenstein, Else A. Aalbersberg et al. · Clinical Nuclear Medicine · 2022 · 11 citations